Literature DB >> 34001859

Assessing olfactory, memory, social and circadian phenotypes associated with schizophrenia in a genetic model based on Rim.

Sergio Hidalgo1,2, Jorge M Campusano3, James J L Hodge4.   

Abstract

Schizophrenia shows high heritability and several of the genes associated with this disorder are involved in calcium (Ca2+) signalling and synaptic function. One of these is the Rab-3 interacting molecule-1 (RIM1), which has recently been associated with schizophrenia by Genome Wide Association Studies (GWAS). However, its contribution to the pathophysiology of this disorder remains unexplored. In this work, we use Drosophila mutants of the orthologue of RIM1, Rim, to model some aspects of the classical and non-classical symptoms of schizophrenia. Rim mutants showed several behavioural features relevant to schizophrenia including social distancing and altered olfactory processing. These defects were accompanied by reduced evoked Ca2+ influx and structural changes in the presynaptic terminals sent by the primary olfactory neurons to higher processing centres. In contrast, expression of Rim-RNAi in the mushroom bodies (MBs), the main memory centre in flies, spared learning and memory suggesting a differential role of Rim in different synapses. Circadian deficits have been reported in schizophrenia. We observed circadian locomotor activity deficits in Rim mutants, revealing a role of Rim in the pacemaker ventral lateral clock neurons (LNvs). These changes were accompanied by impaired day/night remodelling of dorsal terminal synapses from a subpopulation of LNvs and impaired day/night release of the circadian neuropeptide pigment dispersing factor (PDF) from these terminals. Lastly, treatment with the commonly used antipsychotic haloperidol rescued Rim locomotor deficits to wildtype. This work characterises the role of Rim in synaptic functions underlying behaviours disrupted in schizophrenia.

Entities:  

Year:  2021        PMID: 34001859     DOI: 10.1038/s41398-021-01418-3

Source DB:  PubMed          Journal:  Transl Psychiatry        ISSN: 2158-3188            Impact factor:   6.222


  95 in total

Review 1.  Negative symptoms in schizophrenia: a review.

Authors:  J Mäkinen; J Miettunen; M Isohanni; H Koponen
Journal:  Nord J Psychiatry       Date:  2008       Impact factor: 2.202

Review 2.  Negative symptoms: History of the concept and their position in diagnosis of schizophrenia.

Authors:  Sonia Dollfus; John Lyne
Journal:  Schizophr Res       Date:  2016-07-08       Impact factor: 4.939

3.  Prevalence, Employment Rate, and Cost of Schizophrenia in a High-Income Welfare Society: A Population-Based Study Using Comprehensive Health and Welfare Registers.

Authors:  Stig Evensen; Torbjørn Wisløff; June Ullevoldsæter Lystad; Helen Bull; Torill Ueland; Erik Falkum
Journal:  Schizophr Bull       Date:  2015-10-03       Impact factor: 9.306

Review 4.  Sleep, circadian rhythms, and schizophrenia: where we are and where we need to go.

Authors:  Jan Cosgrave; Katharina Wulff; Philip Gehrman
Journal:  Curr Opin Psychiatry       Date:  2018-05       Impact factor: 4.741

5.  De novo gene disruptions in children on the autistic spectrum.

Authors:  Ivan Iossifov; Michael Ronemus; Dan Levy; Zihua Wang; Inessa Hakker; Julie Rosenbaum; Boris Yamrom; Yoon-Ha Lee; Giuseppe Narzisi; Anthony Leotta; Jude Kendall; Ewa Grabowska; Beicong Ma; Steven Marks; Linda Rodgers; Asya Stepansky; Jennifer Troge; Peter Andrews; Mitchell Bekritsky; Kith Pradhan; Elena Ghiban; Melissa Kramer; Jennifer Parla; Ryan Demeter; Lucinda L Fulton; Robert S Fulton; Vincent J Magrini; Kenny Ye; Jennifer C Darnell; Robert B Darnell; Elaine R Mardis; Richard K Wilson; Michael C Schatz; W Richard McCombie; Michael Wigler
Journal:  Neuron       Date:  2012-04-26       Impact factor: 17.173

Review 6.  Olfactory dysfunction in schizophrenia: a review of neuroanatomy and psychophysiological measurements.

Authors:  An D Nguyen; Martha E Shenton; James J Levitt
Journal:  Harv Rev Psychiatry       Date:  2010 Sep-Oct       Impact factor: 3.732

Review 7.  Schizophrenia.

Authors:  René S Kahn; Iris E Sommer; Robin M Murray; Andreas Meyer-Lindenberg; Daniel R Weinberger; Tyrone D Cannon; Michael O'Donovan; Christoph U Correll; John M Kane; Jim van Os; Thomas R Insel
Journal:  Nat Rev Dis Primers       Date:  2015-11-12       Impact factor: 52.329

Review 8.  The molecular genetics of schizophrenia: new findings promise new insights.

Authors:  M J Owen; N M Williams; M C O'Donovan
Journal:  Mol Psychiatry       Date:  2004-01       Impact factor: 15.992

9.  The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia.

Authors:  E K Green; D Grozeva; I Jones; L Jones; G Kirov; S Caesar; K Gordon-Smith; C Fraser; L Forty; E Russell; M L Hamshere; V Moskvina; I Nikolov; A Farmer; P McGuffin; P A Holmans; M J Owen; M C O'Donovan; N Craddock
Journal:  Mol Psychiatry       Date:  2009-07-21       Impact factor: 15.992

Review 10.  Understanding the direct and indirect costs of patients with schizophrenia.

Authors:  Kazuhiro Tajima-Pozo; María Jesús de Castro Oller; Adrian Lewczuk; Francisco Montañes-Rada
Journal:  F1000Res       Date:  2015-07-06
View more
  2 in total

1.  DYRK1a Inhibitor Mediated Rescue of Drosophila Models of Alzheimer's Disease-Down Syndrome Phenotypes.

Authors:  Bangfu Zhu; Tom Parsons; Wenche Stensen; John S Mjøen Svendsen; Anders Fugelli; James J L Hodge
Journal:  Front Pharmacol       Date:  2022-07-19       Impact factor: 5.988

2.  Lipophorin receptors regulate mushroom body development and complex behaviors in Drosophila.

Authors:  Francisca Rojo-Cortés; Nicolás Fuenzalida-Uribe; Victoria Tapia-Valladares; Candy B Roa; Sergio Hidalgo; María-Constanza González-Ramírez; Carlos Oliva; Jorge M Campusano; María-Paz Marzolo
Journal:  BMC Biol       Date:  2022-09-07       Impact factor: 7.364

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.